These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12447699)

  • 1. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor.
    Guo WH; Weng LQ; Ito K; Chen LF; Nakanishi H; Tatematsu M; Ito Y
    Oncogene; 2002 Nov; 21(54):8351-5. PubMed ID: 12447699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
    Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
    Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines.
    Ku JL; Kang SB; Shin YK; Kang HC; Hong SH; Kim IJ; Shin JH; Han IO; Park JG
    Oncogene; 2004 Sep; 23(40):6736-42. PubMed ID: 15273736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
    Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
    Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth regulation of gastric epithelial cells by Runx3.
    Fukamachi H; Ito K
    Oncogene; 2004 May; 23(24):4330-5. PubMed ID: 15156189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.
    Ito K; Liu Q; Salto-Tellez M; Yano T; Tada K; Ida H; Huang C; Shah N; Inoue M; Rajnakova A; Hiong KC; Peh BK; Han HC; Ito T; Teh M; Yeoh KG; Ito Y
    Cancer Res; 2005 Sep; 65(17):7743-50. PubMed ID: 16140942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray.
    So K; Tamura G; Honda T; Homma N; Endoh M; Togawa N; Nishizuka S; Motoyama T
    Pathol Int; 2006 Oct; 56(10):571-5. PubMed ID: 16984612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.
    Wada M; Yazumi S; Takaishi S; Hasegawa K; Sawada M; Tanaka H; Ida H; Sakakura C; Ito K; Ito Y; Chiba T
    Oncogene; 2004 Mar; 23(13):2401-7. PubMed ID: 14743205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
    Kim M; Lee KT; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Kim SY; Yoo HS; Kim YS
    Mol Cancer Res; 2008 Feb; 6(2):222-30. PubMed ID: 18314483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.
    Yanada M; Yaoi T; Shimada J; Sakakura C; Nishimura M; Ito K; Terauchi K; Nishiyama K; Itoh K; Fushiki S
    Oncol Rep; 2005 Oct; 14(4):817-22. PubMed ID: 16142337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
    Lee SH; Kim J; Kim WH; Lee YM
    Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor activity of RUNX3.
    Bae SC; Choi JK
    Oncogene; 2004 May; 23(24):4336-40. PubMed ID: 15156190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
    Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
    Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.
    Kim WJ; Kim EJ; Jeong P; Quan C; Kim J; Li QL; Yang JO; Ito Y; Bae SC
    Cancer Res; 2005 Oct; 65(20):9347-54. PubMed ID: 16230397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
    Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
    Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Promoter methylation and expression of Runx3 gene in gastric cancer].
    Li LY; Li JK; Shen Y; Yu L; Zhang JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):379-82. PubMed ID: 18636364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
    Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment.
    Huang C; Ida H; Ito K; Zhang H; Ito Y
    Biochem Pharmacol; 2007 Apr; 73(7):990-1000. PubMed ID: 17276407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.